- Home
- Publications
- Publication Search
- Publication Details
Title
Pazopanib: an antiangiogenic drug in perspective
Authors
Keywords
-
Journal
Future Oncology
Volume 5, Issue 9, Pages 1335-1348
Publisher
Future Medicine Ltd
Online
2009-11-11
DOI
10.2217/fon.09.112
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Preoperative treatment with pazopanib (GW786034), a multikinase angiogenesis inhibitor in early-stage non-small cell lung cancer (NSCLC): A proof-of-concept phase II study
- (2017) N. Altorki et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II study of sunitinib malate (SM) in subjects with metastatic and/or surgically unresectable non-GIST soft tissue sarcomas
- (2017) C. E. Vigil et al. JOURNAL OF CLINICAL ONCOLOGY
- Updated results of a phase II study of oral multi-kinase inhibitor sorafenib in sarcomas, CTEP study #7060
- (2017) R. G. Maki et al. JOURNAL OF CLINICAL ONCOLOGY
- Continuous daily dosing (CDD) of sunitinib (SU) in patients with metastatic soft tissue sarcomas (STS) other than GIST: Results of a phase II trial
- (2017) M. L. Keohan et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II intergroup study of sorafenib (S) in advanced soft tissue sarcomas (STS): SWOG 0505
- (2017) C. W. Ryan et al. JOURNAL OF CLINICAL ONCOLOGY
- Vascular endothelial growth factor-dependent and -independent regulation of angiogenesis
- (2011) Masabumi Shibuya BMB Reports
- Vascular endothelial growth factor inhibition is not an effective therapeutic strategy for relapsed or refractory multiple myeloma: a phase 2 study of pazopanib (GW786034): Table 1
- (2009) H. Miles Prince et al. BLOOD
- Prognostic role of vascular endothelial growth factor in hepatocellular carcinoma: systematic review and meta-analysis
- (2009) S J Schoenleber et al. BRITISH JOURNAL OF CANCER
- Phase I Trial of Pazopanib in Patients with Advanced Cancer
- (2009) H. I. Hurwitz et al. CLINICAL CANCER RESEARCH
- Antiangiogenic therapy in nonsmall cell lung cancer
- (2009) Martin Gutierrez et al. CURRENT OPINION IN ONCOLOGY
- Survival After Second Primary Neoplasms of the Brain or Spinal Cord in Survivors of Childhood Cancer: Results From the British Childhood Cancer Survivor Study
- (2009) Aliki J. Taylor et al. JOURNAL OF CLINICAL ONCOLOGY
- Multinational, Double-Blind, Phase III Study of Prednisone and Either Satraplatin or Placebo in Patients With Castrate-Refractory Prostate Cancer Progressing After Prior Chemotherapy: The SPARC Trial
- (2009) Cora N. Sternberg et al. JOURNAL OF CLINICAL ONCOLOGY
- Pazopanib, a Multikinase Angiogenesis Inhibitor, in Patients With Relapsed or Refractory Advanced Soft Tissue Sarcoma: A Phase II Study From the European Organisation for Research and Treatment of Cancer–Soft Tissue and Bone Sarcoma Group (EORTC Study 62043)
- (2009) Stefan Sleijfer et al. JOURNAL OF CLINICAL ONCOLOGY
- Sorafenib for Treatment of Renal Cell Carcinoma: Final Efficacy and Safety Results of the Phase III Treatment Approaches in Renal Cancer Global Evaluation Trial
- (2009) Bernard Escudier et al. JOURNAL OF CLINICAL ONCOLOGY
- Overall Survival and Updated Results for Sunitinib Compared With Interferon Alfa in Patients With Metastatic Renal Cell Carcinoma
- (2009) Robert J. Motzer et al. JOURNAL OF CLINICAL ONCOLOGY
- Adverse effects of anticancer agents that target the VEGF pathway
- (2009) Helen X. Chen et al. Nature Reviews Clinical Oncology
- Vascular Changes in Hepatocellular Carcinoma
- (2008) Zhen Fan Yang et al. Anatomical Record-Advances in Integrative Anatomy and Evolutionary Biology
- chest tumors
- (2008) ANNALS OF ONCOLOGY
- Tumoral Angiogenesis: Review of the Literature
- (2008) Parham Khosravi Shahi et al. CANCER INVESTIGATION
- The potential of anti-vascular endothelial growth factor therapy in metastatic breast cancer: Clinical experience with anti-angiogenic agents, focusing on bevacizumab
- (2008) Michel Marty et al. EUROPEAN JOURNAL OF CANCER
- Pazopanib, a potent orally administered small-molecule multitargeted tyrosine kinase inhibitor for renal cell carcinoma
- (2008) Guru Sonpavde et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Combined anti-PDGFRα and PDGFRβ targeting in non-small cell lung cancer
- (2008) Niels Reinmuth et al. INTERNATIONAL JOURNAL OF CANCER
- Recurrent Priapism Related to Oxaliplatin Infusion
- (2008) Antoine Adenis et al. JOURNAL OF CLINICAL ONCOLOGY
- Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III Study
- (2008) Leonard B. Saltz et al. JOURNAL OF CLINICAL ONCOLOGY
- Safety and Efficacy of Oxaliplatin and Fluoropyrimidine Regimens With or Without Bevacizumab As First-Line Treatment of Metastatic Colorectal Cancer: Results of the TREE Study
- (2008) Howard S. Hochster et al. JOURNAL OF CLINICAL ONCOLOGY
- Discovery of 5-[[4-[(2,3-Dimethyl-2H-indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-methyl-benzenesulfonamide (Pazopanib), a Novel and Potent Vascular Endothelial Growth Factor Receptor Inhibitor†
- (2008) Philip A. Harris et al. JOURNAL OF MEDICINAL CHEMISTRY
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
- Therapeutic Application of Noncytotoxic Molecular Targeted Therapy in Gliomas: Growth Factor Receptors and Angiogenesis Inhibitors
- (2008) A. Idbaih et al. ONCOLOGIST
- Targeted Therapies for Metastatic Renal Cell Carcinoma: An Overview of Toxicity and Dosing Strategies
- (2008) T. E. Hutson et al. ONCOLOGIST
- Angiogenesis as a strategic target for ovarian cancer therapy
- (2008) Whitney A Spannuth et al. Nature clinical practice. Oncology
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started